Showing 5,201 - 5,220 results of 104,085 for search '(( 5 ((we decrease) OR (a decrease)) ) OR ( 50 ((greater decrease) OR (mean decrease)) ))', query time: 1.64s Refine Results
  1. 5201
  2. 5202
  3. 5203
  4. 5204
  5. 5205
  6. 5206
  7. 5207
  8. 5208
  9. 5209
  10. 5210
  11. 5211

    <i>Oenocarpus bacaba</i> palm tree (A) and fruit (B). by Eudes Alves Simões-Neto (19697968)

    Published 2024
    “…Serological cure was achieved in 34.6% of cases, and IgG titers decreased in 15.3%.</p><p>Conclusions and significance</p><p>We encountered several barriers in managing ACD, including population vulnerability, reliance on outdated diagnostic techniques, lack of standardized molecular biology methods, and limited therapeutic options. …”
  12. 5212
  13. 5213
  14. 5214
  15. 5215

    This is the raw data used for this study. by James M. Friedman (22522150)

    Published 2025
    “…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”
  16. 5216

    Pre-operative versus post-operative symptoms. by James M. Friedman (22522150)

    Published 2025
    “…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”
  17. 5217

    Patient Demographics. by James M. Friedman (22522150)

    Published 2025
    “…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”
  18. 5218

    Diagnostic Criteria for Human Disharmony Loop. by James M. Friedman (22522150)

    Published 2025
    “…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”
  19. 5219
  20. 5220